UNSPSC 51263137: Xipranolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C23H33NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZJI41P5WMH, chemically known as 2-propanol, 1-(di-2,6-xylylmethoxy)-3-(isopropylamino)- but generally known as xipranolol, which bears US NIH Compound Identifier 65692. European Medicines Agency schedules Xipranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00117MIG.

UNSPSC 51263137 Xipranolol is a Commodity code that in recent state and local procurement activity covers pharmaceutical products used for community health interventions, specifically naloxone and drug deactivation systems. The code encompasses prescription and over-the-counter medications and related medical supplies that state and local health departments, county health agencies, and community health authorities acquire to support public health programs, emergency response, and substance-abuse mitigation initiatives. Issuing bodies under this code include county government health and human services departments pursuing direct purchase or supply agreements to stock medical inventories at fixed or episodic intervals.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation required electronic bid submission through the county e-Procurement Portal with a response deadline of July 26, 2023, at 2:00 pm; bidders had to include all shipping and delivery costs in their proposal and meet E-Verify and drug-free workplace certification requirements. The contract carried an initial two-year term with a one-year renewal option and compliance conditions potentially linked to FEMA funding, including adherence to the Clean Air Act and Federal Water Pollution Control Act.